The digital sphygmomanometer market size was valued for $942.55 million in 2021 and is estimated to reach $1,560.50 million by 2031, exhibiting a CAGR of 5.2% from 2022 to 2031. A digital sphygmomanometer or blood pressure (BP) monitor is a device that measures blood pressure, particularly in arteries and displays digital reading. Blood pressure is one of the main risk factors for chronic heart diseases, which are the leading cause of death around the world.
This has led to importance of blood pressure monitoring devices in home care settings and demand of advanced technologies. It is composed of an inflatable rubber cuff, which is wrapped around the arm, a measuring device indicates the cuff's pressure, bulb inflates the cuff and a valve which releases pressure. It is also known as arm type digital sphygmomanometer. The wrist type digital sphygmomanometers measure the vibration of blood flowing through the arteries in the wrist.
The blood pressure is primarily monitored at home or outside a hospital, clinic, or office setting. The measuring devices are usually of three types: mercury sphygmomanometers, an aneroid sphygmomanometer and electronic/digital sphygmomanometer, The digital sphygmomanometers are being adopted and preferred owing to toxicity issues of mercury sphygmomanometers and noise & error issues of aneroid sphygmomanometer. An oscillometric measuring method is used by a digital or electronic sphygmomanometer. It is simple to use, battery-powered, automated, and devoid of mercury.
The driving factors for digital sphygmomanometer market are rise in prevalence of blood - related disorders such as hypertension, increase in innovations in digital sphygmomanometer devices and rise in adoption of digital sphygmomanometers instead of traditional mercury base sphygmomanometers. Hypertension or high blood pressure is major cause of death worldwide and rise in prevalence of high blood pressure cases, results in demand of blood pressure monitoring devices.
For instance, according to article published in World Heart Federation 2021, stated that, nearly 1.3 billion people suffer from hypertension worldwide and only 1 in 5 individuals have their blood pressure under control, thus require continuous monitoring.
The digital sphygmomanometers are being used owing to its portable characteristics, patient comfort, battery operated and easy to use, thereby drives the growth of market. Further, new product launches and innovations in digital sphygmomanometer is anticipated to contribute to growth of market during forecast period. For instance, Omron Corporation (Omron Healthcare) officially launches HeartGuide, the first wearable blood pressure monitor, with new digital health service, HeartAdvisor, thus availability of such innovative digital sphygmomanometers is expected to drive the growth of market.
However, high cost of digital sphygmomanometers is projected to restrain the growth of digital sphygmomanometer market. In addition, due to the digital sphygmomanometer's enhanced sensitivity, body movements during blood pressure monitoring may compromise its accuracy, which might restrain the market growth.
The digital sphygmomanometer market is segmented into type, end user and region. By type, the market is categorized into arm devices and wrist devices. On the basis of end user, the market is segregated into hospitals and clinics, home care settings and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major Key players that operate in the global digital sphygmomanometer market are A&D HOLON Holdings Company Limited (A&D Company, Limited), American Diagnostic Corporation, Baxter International Inc. (Hill-Rom Holdings, Inc), Contec Medical Systems Co.,Ltd, Halma plc (Rudolf Riester gmbh), Microlife Corporation, OMRON Corporation (Omron Healthcare, Inc), Panasonic Holdings Corporation, Rossmax International Ltd and Yu Yue Medical.
This has led to importance of blood pressure monitoring devices in home care settings and demand of advanced technologies. It is composed of an inflatable rubber cuff, which is wrapped around the arm, a measuring device indicates the cuff's pressure, bulb inflates the cuff and a valve which releases pressure. It is also known as arm type digital sphygmomanometer. The wrist type digital sphygmomanometers measure the vibration of blood flowing through the arteries in the wrist.
The blood pressure is primarily monitored at home or outside a hospital, clinic, or office setting. The measuring devices are usually of three types: mercury sphygmomanometers, an aneroid sphygmomanometer and electronic/digital sphygmomanometer, The digital sphygmomanometers are being adopted and preferred owing to toxicity issues of mercury sphygmomanometers and noise & error issues of aneroid sphygmomanometer. An oscillometric measuring method is used by a digital or electronic sphygmomanometer. It is simple to use, battery-powered, automated, and devoid of mercury.
The driving factors for digital sphygmomanometer market are rise in prevalence of blood - related disorders such as hypertension, increase in innovations in digital sphygmomanometer devices and rise in adoption of digital sphygmomanometers instead of traditional mercury base sphygmomanometers. Hypertension or high blood pressure is major cause of death worldwide and rise in prevalence of high blood pressure cases, results in demand of blood pressure monitoring devices.
For instance, according to article published in World Heart Federation 2021, stated that, nearly 1.3 billion people suffer from hypertension worldwide and only 1 in 5 individuals have their blood pressure under control, thus require continuous monitoring.
The digital sphygmomanometers are being used owing to its portable characteristics, patient comfort, battery operated and easy to use, thereby drives the growth of market. Further, new product launches and innovations in digital sphygmomanometer is anticipated to contribute to growth of market during forecast period. For instance, Omron Corporation (Omron Healthcare) officially launches HeartGuide, the first wearable blood pressure monitor, with new digital health service, HeartAdvisor, thus availability of such innovative digital sphygmomanometers is expected to drive the growth of market.
However, high cost of digital sphygmomanometers is projected to restrain the growth of digital sphygmomanometer market. In addition, due to the digital sphygmomanometer's enhanced sensitivity, body movements during blood pressure monitoring may compromise its accuracy, which might restrain the market growth.
The digital sphygmomanometer market is segmented into type, end user and region. By type, the market is categorized into arm devices and wrist devices. On the basis of end user, the market is segregated into hospitals and clinics, home care settings and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major Key players that operate in the global digital sphygmomanometer market are A&D HOLON Holdings Company Limited (A&D Company, Limited), American Diagnostic Corporation, Baxter International Inc. (Hill-Rom Holdings, Inc), Contec Medical Systems Co.,Ltd, Halma plc (Rudolf Riester gmbh), Microlife Corporation, OMRON Corporation (Omron Healthcare, Inc), Panasonic Holdings Corporation, Rossmax International Ltd and Yu Yue Medical.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the digital sphygmomanometer market analysis from 2021 to 2031 to identify the prevailing digital sphygmomanometer market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the digital sphygmomanometer market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global digital sphygmomanometer market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
- Arm Type
- Wrist Type
- Hospitals and clinics
- Home care settings
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Baxter International Inc.
- Contec Medical Systems Co.,Ltd
- OMRON Corporation
- A&D HOLON Holdings Company, Limited
- Microlife Corporation
- Panasonic Holdings Corporation
- Halma plc
- Rossmax International Ltd
- American Diagnostic Corporation
- Yu Yue Medical
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Moderate bargaining power of buyers
3.3.3. Moderate threat of substitutes
3.3.4. Moderate threat of new entrants
3.3.5. High intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of high blood pressure cases
3.4.1.2. Technological advancements in digital sphygmomanometer
3.4.1.3. Government initiatives regarding hypertension and monitoring
3.4.2. Restraints
3.4.2.1. Less accuracy in results obtained by digital sphygmomanometer
3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: DIGITAL SPHYGMOMANOMETER MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Arm Type
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Wrist Type
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
CHAPTER 5: DIGITAL SPHYGMOMANOMETER MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. Hospitals and clinics
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Home care settings
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Others
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
CHAPTER 6: DIGITAL SPHYGMOMANOMETER MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast By Region
6.2. North America
6.2.1. Key trends and opportunities
6.2.2. Market size and forecast, by Type
6.2.3. Market size and forecast, by End User
6.2.4. Market size and forecast, by country
6.2.4.1. U.S.
6.2.4.1.1. Key market trends, growth factors and opportunities
6.2.4.1.2. Market size and forecast, by Type
6.2.4.1.3. Market size and forecast, by End User
6.2.4.2. Canada
6.2.4.2.1. Key market trends, growth factors and opportunities
6.2.4.2.2. Market size and forecast, by Type
6.2.4.2.3. Market size and forecast, by End User
6.2.4.3. Mexico
6.2.4.3.1. Key market trends, growth factors and opportunities
6.2.4.3.2. Market size and forecast, by Type
6.2.4.3.3. Market size and forecast, by End User
6.3. Europe
6.3.1. Key trends and opportunities
6.3.2. Market size and forecast, by Type
6.3.3. Market size and forecast, by End User
6.3.4. Market size and forecast, by country
6.3.4.1. Germany
6.3.4.1.1. Key market trends, growth factors and opportunities
6.3.4.1.2. Market size and forecast, by Type
6.3.4.1.3. Market size and forecast, by End User
6.3.4.2. France
6.3.4.2.1. Key market trends, growth factors and opportunities
6.3.4.2.2. Market size and forecast, by Type
6.3.4.2.3. Market size and forecast, by End User
6.3.4.3. UK
6.3.4.3.1. Key market trends, growth factors and opportunities
6.3.4.3.2. Market size and forecast, by Type
6.3.4.3.3. Market size and forecast, by End User
6.3.4.4. Italy
6.3.4.4.1. Key market trends, growth factors and opportunities
6.3.4.4.2. Market size and forecast, by Type
6.3.4.4.3. Market size and forecast, by End User
6.3.4.5. Spain
6.3.4.5.1. Key market trends, growth factors and opportunities
6.3.4.5.2. Market size and forecast, by Type
6.3.4.5.3. Market size and forecast, by End User
6.3.4.6. Rest of Europe
6.3.4.6.1. Key market trends, growth factors and opportunities
6.3.4.6.2. Market size and forecast, by Type
6.3.4.6.3. Market size and forecast, by End User
6.4. Asia-Pacific
6.4.1. Key trends and opportunities
6.4.2. Market size and forecast, by Type
6.4.3. Market size and forecast, by End User
6.4.4. Market size and forecast, by country
6.4.4.1. Japan
6.4.4.1.1. Key market trends, growth factors and opportunities
6.4.4.1.2. Market size and forecast, by Type
6.4.4.1.3. Market size and forecast, by End User
6.4.4.2. China
6.4.4.2.1. Key market trends, growth factors and opportunities
6.4.4.2.2. Market size and forecast, by Type
6.4.4.2.3. Market size and forecast, by End User
6.4.4.3. India
6.4.4.3.1. Key market trends, growth factors and opportunities
6.4.4.3.2. Market size and forecast, by Type
6.4.4.3.3. Market size and forecast, by End User
6.4.4.4. Australia
6.4.4.4.1. Key market trends, growth factors and opportunities
6.4.4.4.2. Market size and forecast, by Type
6.4.4.4.3. Market size and forecast, by End User
6.4.4.5. South Korea
6.4.4.5.1. Key market trends, growth factors and opportunities
6.4.4.5.2. Market size and forecast, by Type
6.4.4.5.3. Market size and forecast, by End User
6.4.4.6. Rest of Asia-Pacific
6.4.4.6.1. Key market trends, growth factors and opportunities
6.4.4.6.2. Market size and forecast, by Type
6.4.4.6.3. Market size and forecast, by End User
6.5. LAMEA
6.5.1. Key trends and opportunities
6.5.2. Market size and forecast, by Type
6.5.3. Market size and forecast, by End User
6.5.4. Market size and forecast, by country
6.5.4.1. Brazil
6.5.4.1.1. Key market trends, growth factors and opportunities
6.5.4.1.2. Market size and forecast, by Type
6.5.4.1.3. Market size and forecast, by End User
6.5.4.2. Saudi Arabia
6.5.4.2.1. Key market trends, growth factors and opportunities
6.5.4.2.2. Market size and forecast, by Type
6.5.4.2.3. Market size and forecast, by End User
6.5.4.3. South Africa
6.5.4.3.1. Key market trends, growth factors and opportunities
6.5.4.3.2. Market size and forecast, by Type
6.5.4.3.3. Market size and forecast, by End User
6.5.4.4. Rest of LAMEA
6.5.4.4.1. Key market trends, growth factors and opportunities
6.5.4.4.2. Market size and forecast, by Type
6.5.4.4.3. Market size and forecast, by End User
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2021
CHAPTER 8: COMPANY PROFILES
8.1. Baxter International Inc.
8.1.1. Company overview
8.1.2. Key Executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Business performance
8.1.7. Key strategic moves and developments
8.2. Contec Medical Systems Co.,Ltd
8.2.1. Company overview
8.2.2. Key Executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.3. Microlife Corporation
8.3.1. Company overview
8.3.2. Key Executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.4. Panasonic Holdings Corporation
8.4.1. Company overview
8.4.2. Key Executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. Business performance
8.5. Halma plc
8.5.1. Company overview
8.5.2. Key Executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.5.6. Business performance
8.6. OMRON Corporation
8.6.1. Company overview
8.6.2. Key Executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.6.6. Business performance
8.6.7. Key strategic moves and developments
8.7. A&D HOLON Holdings Company, Limited
8.7.1. Company overview
8.7.2. Key Executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.7.6. Business performance
8.8. Rossmax International Ltd
8.8.1. Company overview
8.8.2. Key Executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.9. American Diagnostic Corporation
8.9.1. Company overview
8.9.2. Key Executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.9.6. Key strategic moves and developments
8.10. Yu Yue Medical
8.10.1. Company overview
8.10.2. Key Executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio
List of Tables
Table 01. Global Digital Sphygmomanometer Market, by Type, 2021-2031 (Revenue, $Million)
Table 02. Digital Sphygmomanometer Market for Arm Type, by Region, 2021-2031 (Revenue, $Million)
Table 03. Digital Sphygmomanometer Market for Wrist Type, by Region, 2021-2031 (Revenue, $Million)
Table 04. Global Digital Sphygmomanometer Market, by End-user, 2021-2031 (Revenue, $Million)
Table 05. Digital Sphygmomanometer Market for Hospitals and Clinics, by Region, 2021-2031 (Revenue, $Million)
Table 06. Digital Sphygmomanometer Market for Home Care Settings, by Region, 2021-2031 (Revenue, $Million)
Table 07. Digital Sphygmomanometer Market for Others, by Region, 2021-2031 (Revenue, $Million)
Table 8. Digital Sphygmomanometer Market, by Region, 2021-2031 (Revenue, $Million)
Table 9. North America Digital Sphygmomanometer Market, by Type, 2021-2031 (Revenue, $Million)
Table 10. North America Digital Sphygmomanometer Market, by End-user, 2021-2031 (Revenue, $Million)
Table 11. North America Digital Sphygmomanometer Market, by Country, 2021-2031 (Revenue, $Million)
Table 12. U.S. Digital Sphygmomanometer Market, by Type, 2021-2031 (Revenue, $Million)
Table 13. U.S. Digital Sphygmomanometer Market, by End-user, 2021-2031 (Revenue, $Million)
Table 14. Canada Digital Sphygmomanometer Market, by Type, 2021-2031 (Revenue, $Million)
Table 15. Canada Digital Sphygmomanometer Market, by End-user, 2021-2031 (Revenue, $Million)
Table 16. Mexico Digital Sphygmomanometer Market, by Type, 2021-2031 (Revenue, $Million)
Table 17. Mexico Digital Sphygmomanometer Market, by End-user, 2021-2031 (Revenue, $Million)
Table 18. Europe Digital Sphygmomanometer Market, by Type, 2021-2031 (Revenue, $Million)
Table 19. Europe Digital Sphygmomanometer Market, by End-user, 2021-2031 (Revenue, $Million)
Table 20. Europe Digital Sphygmomanometer Market, by Country, 2021-2031 (Revenue, $Million)
Table 21. Germany Digital Sphygmomanometer Market, by Type, 2021-2031 (Revenue, $Million)
Table 22. Germany Digital Sphygmomanometer Market, by End-user, 2021-2031 (Revenue, $Million)
Table 23. France Digital Sphygmomanometer Market, by Type, 2021-2031 (Revenue, $Million)
Table 24. France Digital Sphygmomanometer Market, by End-user, 2021-2031 (Revenue, $Million)
Table 25. UK Digital Sphygmomanometer Market, by Type, 2021-2031 (Revenue, $Million)
Table 26. UK Digital Sphygmomanometer Market, by End-user, 2021-2031 (Revenue, $Million)
Table 27. Italy Digital Sphygmomanometer Market, by Type, 2021-2031 (Revenue, $Million)
Table 28. Italy Digital Sphygmomanometer Market, by End-user, 2021-2031 (Revenue, $Million)
Table 29. Spain Digital Sphygmomanometer Market, by Type, 2021-2031 (Revenue, $Million)
Table 30. Spain Digital Sphygmomanometer Market, by End-user, 2021-2031 (Revenue, $Million)
Table 31. Rest of Europe Digital Sphygmomanometer Market, by Type, 2021-2031 (Revenue, $Million)
Table 32. Rest of Europe Digital Sphygmomanometer Market, by End-user, 2021-2031 (Revenue, $Million)
Table 33. Asia-Pacific Digital Sphygmomanometer Market, by Type, 2021-2031 (Revenue, $Million)
Table 34. Asia-Pacific Digital Sphygmomanometer Market, by End-user, 2021-2031 (Revenue, $Million)
Table 35. Asia-Pacific Digital Sphygmomanometer Market, by Country, 2021-2031 (Revenue, $Million)
Table 36. Japan Digital Sphygmomanometer Market, by Type, 2021-2031 (Revenue, $Million)
Table 37. Japan Digital Sphygmomanometer Market, by End-user, 2021-2031 (Revenue, $Million)
Table 38. China Digital Sphygmomanometer Market, by Type, 2021-2031 (Revenue, $Million)
Table 39. China Digital Sphygmomanometer Market, by End-user, 2021-2031 (Revenue, $Million)
Table 40. India Digital Sphygmomanometer Market, by Type, 2021-2031 (Revenue, $Million)
Table 41. India Digital Sphygmomanometer Market, by End-user, 2021-2031 (Revenue, $Million)
Table 42. Australia Digital Sphygmomanometer Market, by Type, 2021-2031 (Revenue, $Million)
Table 43. Australia Digital Sphygmomanometer Market, by End-user, 2021-2031 (Revenue, $Million)
Table 44. South Korea Digital Sphygmomanometer Market, by Type, 2021-2031 (Revenue, $Million)
Table 45. South Korea Digital Sphygmomanometer Market, by End-user, 2021-2031 (Revenue, $Million)
Table 46. Rest of Asia-Pacific Digital Sphygmomanometer Market, by Type, 2021-2031 (Revenue, $Million)
Table 47. Rest of Asia-Pacific Digital Sphygmomanometer Market, by End-user, 2021-2031 (Revenue, $Million)
Table 48. LAMEA Digital Sphygmomanometer Market, by Type, 2021-2031 (Revenue, $Million)
Table 49. LAMEA Digital Sphygmomanometer Market, by End-user, 2021-2031 (Revenue, $Million)
Table 50. LAMEA Digital Sphygmomanometer Market, by Country, 2021-2031 (Revenue, $Million)
Table 51. Brazil Digital Sphygmomanometer Market, by Type, 2021-2031 (Revenue, $Million)
Table 52. Brazil Digital Sphygmomanometer Market, by End-user, 2021-2031 (Revenue, $Million)
Table 53. Saudi Arabia Digital Sphygmomanometer Market, by Type, 2021-2031 (Revenue, $Million)
Table 54. Saudi Arabia Digital Sphygmomanometer Market, by End-user, 2021-2031 (Revenue, $Million)
Table 55. South Africa Digital Sphygmomanometer Market, by Type, 2021-2031 (Revenue, $Million)
Table 56. South Africa Digital Sphygmomanometer Market, by End-user, 2021-2031 (Revenue, $Million)
Table 57. Rest of LAMEA Digital Sphygmomanometer Market, by Type, 2021-2031 (Revenue, $Million)
Table 58. Rest of LAMEA Digital Sphygmomanometer Market, by End-user, 2021-2031 (Revenue, $Million)
Table 59. Baxter International Inc.: Key Executives
Table 60. Baxter International Inc.: Company Snapshot
Table 61. Baxter International Inc.: Product Segments
Table 62. Baxter International Inc.: Product Portfolio
Table 63. Baxter International Inc.: Key Stratergies
Table 64. Contec Medical Systems Co.Ltd: Key Executives
Table 65. Contec Medical Systems Co.Ltd: Company Snapshot
Table 66. Contec Medical Systems Co.Ltd: Product Segments
Table 67. Contec Medical Systems Co.Ltd: Product Portfolio
Table 68. Microlife Corporation: Key Executives
Table 69. Microlife Corporation: Company Snapshot
Table 70. Microlife Corporation: Product Segments
Table 71. Microlife Corporation: Product Portfolio
Table 72. Panasonic Holdings Corporation: Key Executives
Table 73. Panasonic Holdings Corporation: Company Snapshot
Table 74. Panasonic Holdings Corporation: Product Segments
Table 75. Panasonic Holdings Corporation: Product Portfolio
Table 76. Halma plc: Key Executives
Table 77. Halma plc: Company Snapshot
Table 78. Halma plc: Product Segments
Table 79. Halma plc: Product Portfolio
Table 80. Omron Corporation: Key Executives
Table 81. Omron Corporation: Company Snapshot
Table 82. Omron Corporation: Service Segments
Table 83. Omron Corporation: Product Portfolio
Table 84. Omron Corporation: Key Stratergies
Table 85. A&D Holon Holdings Company, Limited: Key Executives
Table 86. A&D Holon Holdings Company, Limited: Company Snapshot
Table 87. A&D Holon Holdings Company, Limited: Product Segments
Table 88. A&D Holon Holdings Company, Limited: Product Portfolio
Table 89. Rossmax International Ltd: Key Executives
Table 90. Rossmax International Ltd: Company Snapshot
Table 91. Rossmax International Ltd: Product Segments
Table 92. Rossmax International Ltd: Product Portfolio
Table 93. American Diagnostic Corporation: Key Executives
Table 94. American Diagnostic Corporation: Company Snapshot
Table 95. American Diagnostic Corporation: Product Segments
Table 96. American Diagnostic Corporation: Product Portfolio
Table 97. American Diagnostic Corporation: Key Stratergies
Table 98. Yu Yue Medical: Key Executives
Table 99. Yu Yue Medical: Company Snapshot
Table 100. Yu Yue Medical: Product Segments
Table 101. Yu Yue Medical: Product Portfolio
List of Figures
Figure 01. Digital Sphygmomanometer Market, 2021-2031
Figure 02. Segmentation of Digital Sphygmomanometer Market, 2021-2031
Figure 03. Top Investment Pockets in Digital Sphygmomanometer Market (2022-2031)
Figure 04. Moderate Bargaining Power of Suppliers
Figure 05. Moderate Bargaining Power of Buyers
Figure 06. Moderate Threat of Substitutes
Figure 07. Moderate Threat of New Entrants
Figure 08. High Intensity of Rivalry
Figure 09. Drivers, Restraints and Opportunities: Globaldigital Sphygmomanometer Market
Figure 10. Digital Sphygmomanometer Market, by Type, 2021 (%)
Figure 11. Comparative Share Analysis of Digital Sphygmomanometer Market for Arm Type, by Country 2021-2031 (%)
Figure 12. Comparative Share Analysis of Digital Sphygmomanometer Market for Wrist Type, by Country 2021-2031 (%)
Figure 13. Digital Sphygmomanometer Market, by End-user, 2021 (%)
Figure 14. Comparative Share Analysis of Digital Sphygmomanometer Market for Hospitals and Clinics, by Country 2021-2031 (%)
Figure 15. Comparative Share Analysis of Digital Sphygmomanometer Market for Home Care Settings, by Country 2021-2031 (%)
Figure 16. Comparative Share Analysis of Digital Sphygmomanometer Market for Others, by Country 2021-2031 (%)
Figure 17. Digital Sphygmomanometer Market by Region, 2021
Figure 18. U.S. Digital Sphygmomanometer Market, 2021-2031 ($Million)
Figure 19. Canada Digital Sphygmomanometer Market, 2021-2031 ($Million)
Figure 20. Mexico Digital Sphygmomanometer Market, 2021-2031 ($Million)
Figure 21. Germany Digital Sphygmomanometer Market, 2021-2031 ($Million)
Figure 22. France Digital Sphygmomanometer Market, 2021-2031 ($Million)
Figure 23. UK Digital Sphygmomanometer Market, 2021-2031 ($Million)
Figure 24. Italy Digital Sphygmomanometer Market, 2021-2031 ($Million)
Figure 25. Spain Digital Sphygmomanometer Market, 2021-2031 ($Million)
Figure 26. Rest of Europe Digital Sphygmomanometer Market, 2021-2031 ($Million)
Figure 27. Japan Digital Sphygmomanometer Market, 2021-2031 ($Million)
Figure 28. China Digital Sphygmomanometer Market, 2021-2031 ($Million)
Figure 29. India Digital Sphygmomanometer Market, 2021-2031 ($Million)
Figure 30. Australia Digital Sphygmomanometer Market, 2021-2031 ($Million)
Figure 31. South Korea Digital Sphygmomanometer Market, 2021-2031 ($Million)
Figure 32. Rest of Asia-Pacific Digital Sphygmomanometer Market, 2021-2031 ($Million)
Figure 33. Brazil Digital Sphygmomanometer Market, 2021-2031 ($Million)
Figure 34. Saudi Arabia Digital Sphygmomanometer Market, 2021-2031 ($Million)
Figure 35. South Africa Digital Sphygmomanometer Market, 2021-2031 ($Million)
Figure 36. Rest of LAMEA Digital Sphygmomanometer Market, 2021-2031 ($Million)
Figure 37. Top Winning Strategies, by Year
Figure 38. Top Winning Strategies, by Development
Figure 39. Top Winning Strategies, by Company
Figure 40. Product Mapping of Top 10 Players
Figure 41. Competitive Dashboard
Figure 42. Competitive Heatmap: Digital Sphygmomanometer Market
Figure 43. Top Player Positioning, 2021
Figure 44. Baxter International Inc.: Net Sales, 2019-2021 ($Million)
Figure 45. Baxter International Inc.: Revenue Share by Segment, 2021 (%)
Figure 46. Baxter International Inc.: Revenue Share by Region, 2021 (%)
Figure 47. Panasonic Holdings Corporation: Net Sales, 2019-2021 ($Million)
Figure 48. Panasonic Holdings Corporation: Revenue Share by Segment, 2021 (%)
Figure 49. Panasonic Holdings Corporation: Revenue Share by Region, 2021 (%)
Figure 50. Halma plc: Net Sales, 2020-2022 ($Million)
Figure 51. Halma plc: Research & Development Expenditure, 2020-2022
Figure 52. Halma plc: Revenue Share by Segment, 2022 (%)
Figure 53. Halma plc: Revenue Share by Region, 2022 (%)
Figure 54. Omron Corporation: Net Revenue, 2020-2022 ($Million)
Figure 55. Omron Corporation: Revenue Share by Segment, 2022 (%)
Figure 56. Omron Corporation: Revenue Share by Region, 2022 (%)
Figure 57. A&D Holon Holdings Company, Limited: Net Sales, 2019-2021 ($Million)
Figure 58. A&D Holon Holdings Company, Limited: Revenue Share by Segment, 2021 (%)
Executive Summary
According to the report titled, “Digital Sphygmomanometer Market," The digital sphygmomanometer market size was valued at $942.55 million in 2021, and is estimated to reach $1,560.50 million by 2031, growing at a CAGR of 5.2% from 2022 to 2031.Sphygmomanometers are medical devices that are used to measure blood pressure (mainly in arteries). Blood pressure is one of the main risk factors for chronic heart diseases, which are the leading cause of death around the world. This has led to importance of blood pressure monitoring devices in home care settings and demand of advanced technologies. It is composed of an inflatable rubber cuff, which is wrapped around the arm, a measuring device indicates the cuff's pressure, bulb inflates the cuff and a valve which releases pressure. It is also known as arm type digital sphygmomanometer. The wrist type digital sphygmomanometers measure the vibration of blood flowing through the arteries in the wrist. The blood pressure is primarily monitored at home or outside a hospital, clinic, or office setting. The measuring devices are usually of three types: mercury sphygmomanometers, an aneroid sphygmomanometer and electronic/digital sphygmomanometer, The digital sphygmomanometers are being adopted and preferred owing to toxicity issues of mercury sphygmomanometers and noise & error issues of aneroid sphygmomanometer. An oscillometric measuring method is used by a digital or electronic sphygmomanometer. It is simple to use, battery-powered, automated, and devoid of mercury.
Key factors driving the growth of the microbiome sequencing market are increase in technological advancements in digital sphygmomanometer, surge in number of hypertension cases and increase in number of key players offering digital sphygmomanometer. Increase in number of hypertension cases across the world and increase in number of adults diagnosing high blood pressure, which results in demand of advanced digital sphygmomanometer devices, driving the growth of market. For instance, according to data of World Health Organization (WHO) 2021, stated that, 1.28 billion adults aged 30-79 years worldwide suffer from high blood pressure, with majority of cases in low- and middle-income countries, thus rise in high blood pressure cases results in demand of digital sphygmomanometer.
The market also offers growth opportunities to the key players in the market. Many developing regions such India and UK offer lucrative opportunities to key players of digital sphygmomanometer market owing to high population base, increase in demand of advanced portable digital sphygmomanometer and increase in healthcare spending. For instance, American Diagnostic Corporation offers ‘Advantage Connect 6024N automatic digital BP monitor with Bluetooth’ with advantages such as American Heart Association hypertension scale, 99 readings for each user and superior reporting accuracy, thus availability of various digital sphygmomanometers is expected to drive the growth of market. In addition, increase in awareness regarding high blood pressure and early diagnosis using digital sphygmomanometer, is further expected to fuel the growth of market.
The digital sphygmomanometer market is segmented into type, end user and region. By type, the market is categorized into arm devices and wrist devices. On the basis of end user, the market is segregated into hospitals and clinics, home care settings and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major Key players that operate in the global digital sphygmomanometer market are A&D HOLON Holdings Company Limited (A&D Company, Limited), American Diagnostic Corporation, Baxter International Inc. (Hill-Rom Holdings, Inc), Contec Medical Systems Co.,Ltd, Halma plc (Rudolf Riester gmbh), Microlife Corporation, OMRON Corporation (Omron Healthcare, Inc), Panasonic Holdings Corporation, Rossmax International Ltd and Yu Yue Medical.
The players in the market have been actively engaged in the adoption various strategies such as acquisition, product launch, investments, collaboration and strategic alliance to remain competitive and gain advantage over the competitors in the market. For instance, in April 2020, AliveCor, a leader in personal ECG products, and OMRON Healthcare, Co., Ltd., a global leader in personal heart health and wellness technology, announced a global, strategic alliance that combines AliveCor’s ECG technology with industry-leading blood pressure devices from OMRON to better serve customers and expand access to remote patient care.
Key Market Insights (Updated)
- By type, the arm devices segment was the highest revenue contributor to the market in 2021 and is estimated to reach $1,266.81 million by 2031. However, wrist devices segment is estimated to be the fastest-growing segment during the forecast period.
- By end user, the hospitals and clinics segment dominated the market in terms of revenue in 2021. However, home care settings segment is anticipated to grow at the highest CAGR during the forecast period
- Region wise, North America generated the largest revenue in 2021. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- Baxter International Inc.
- Contec Medical Systems Co.,Ltd
- OMRON Corporation
- A&D HOLON Holdings Company, Limited
- Microlife Corporation
- Panasonic Holdings Corporation
- Halma plc
- Rossmax International Ltd
- American Diagnostic Corporation
- Yu Yue Medical
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
